Flavonoid Glycosides from Var. (Bunge) Rehder Seeds Inhibit α-Melanocyte-Stimulating Hormone-Mediated Melanogenesis
Overview
Chemistry
Molecular Biology
Authors
Affiliations
extracts possess a broad spectrum of biological activities, such as antioxidant and anticancer activities in melanoma cancers. Nevertheless, the compounds contain high antioxidant capacities and anticancer activities in melanoma cells, shown to be effective in hyperpigmentation disorders, but whether flavonoid glycosides from . regulate anti-melanogenesis remains unclear. In this study, we evaluated the anti-melanogenic activity of five flavonoid glycosides from var. (Bunge) Rehder seeds, including jujuboside A (JUA), jujuboside B (JUB), epiceanothic acid (EPA), betulin (BTL), and 6'''-feruloylspinosin (FRS), in B16F10 melanoma cells and zebrafish larvae. According to our results, JUB, EPA, and FRS potently inhibited α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis and prevented hyperpigmentation in zebrafish larvae. In particular, under α-MSH-stimulated conditions, FRS most significantly inhibited α-MSH-induced intracellular and extracellular melanin content in B16F10 melanoma cells. Additionally, JUB, EPS, and FRS remarkably downregulated melanogenesis in α-MSH-treated zebrafish larvae, with no significant change in heart rate. Neither JUA nor BTA were effective in downregulating melanogenesis in B16F10 melanoma cells and zebrafish larvae. Furthermore, JUB, EPA, and FRS directly inhibited in vitro mushroom tyrosinase enzyme activity. JUB, EPA, and FRS also downregulated cyclic adenosine monophosphate (cAMP) levels and the phosphorylation of cAMP-response element-binding protein (CREB), and subsequent microphthalmia transcription factor (MITF) and tyrosinase expression. In conclusion, this study demonstrated that JUB, EPA, and FRS isolated from var. (Bunge) Rehder seeds exhibit potent anti-melanogenic properties by inhibition of the cAMP-CERB-MITF axis and consequent tyrosinase activity.
Gou B, Chen G, Huang S, Ning N, Gu Q, Duan S Front Oncol. 2025; 15:1489974.
PMID: 39944835 PMC: 11814214. DOI: 10.3389/fonc.2025.1489974.
Zhai K, Liu G, Cao C, Wang X Oncol Lett. 2025; 29(3):162.
PMID: 39911154 PMC: 11795164. DOI: 10.3892/ol.2025.14908.
Mechanism, Formulation, and Efficacy Evaluation of Natural Products for Skin Pigmentation Treatment.
Peng X, Ma Y, Yan C, Wei X, Zhang L, Jiang H Pharmaceutics. 2024; 16(8).
PMID: 39204367 PMC: 11359997. DOI: 10.3390/pharmaceutics16081022.
A Literature Review of the Pharmacological Effects of Jujube.
Zhu D, Jiang N, Wang N, Zhao Y, Liu X Foods. 2024; 13(2).
PMID: 38254493 PMC: 10814260. DOI: 10.3390/foods13020193.
Tung X, Yip J, Gew L ACS Omega. 2023; 8(37):33115-33201.
PMID: 37744793 PMC: 10515176. DOI: 10.1021/acsomega.3c02994.